
Hepion Pharmaceuticals Inc is a biopharmaceutical company that focuses primarily on the development of drug therapy for the treatment of chronic liver diseases. This therapeutic approach targets fibrosis and hepatocellular carcinoma associated with non-alcoholic steatohepatitis, viral hepatitis, and... Hepion Pharmaceuticals Inc is a biopharmaceutical company that focuses primarily on the development of drug therapy for the treatment of chronic liver diseases. This therapeutic approach targets fibrosis and hepatocellular carcinoma associated with non-alcoholic steatohepatitis, viral hepatitis, and other liver diseases. Its cyclophilin inhibitor, Rencofilstat, is being developed to offer benefits to address these multiple complex pathologies. Rencofilstat is a pan cyclophilin inhibitor that targets multiple pathologic pathways involved in the progression of liver disease. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0.135 | 0.135 | 0.135 | 0 | 0 | CS |
4 | 0 | 0 | 0.135 | 0.135 | 0.135 | 0 | 0 | CS |
12 | -0.163 | -54.6979865772 | 0.298 | 0.49 | 0.1081 | 1181548 | 0.32146809 | CS |
26 | -26.365 | -99.4905660377 | 26.5 | 26.5 | 0.1081 | 11746914 | 5.46372594 | CS |
52 | -50.865 | -99.7352941176 | 51 | 56 | 0.1081 | 5808810 | 5.75923564 | CS |
156 | -619.865 | -99.9782258065 | 620 | 1192.7 | 0.1081 | 2068736 | 49.65536602 | CS |
260 | -3749.865 | -99.9964 | 3750 | 6180 | 0.1081 | 1912974 | 743.90836094 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.